QLF4113 in Participants With Metastatic Prostate Cancer
Clinical trial NCT07636707 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07636707
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-20
- Primary completion
- 2028-01-05
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.